Your browser doesn't support javascript.
loading
The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy.
Buckley, S A; Othus, M; Estey, E H; Walter, R B.
Affiliation
  • Buckley SA; Hematology/Oncology Fellowship Program, University of Washington, Seattle, WA, USA.
  • Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Estey EH; 1] Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA [2] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Walter RB; 1] Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA [2] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [3] Department of Epidemiology, University of Washington, Seattle, WA, USA.
Blood Cancer J ; 5: e276, 2015 Jan 30.
Article in En | MEDLINE | ID: mdl-25635529
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Drug Therapy / Drug-Related Side Effects and Adverse Reactions Type of study: Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2015 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Drug Therapy / Drug-Related Side Effects and Adverse Reactions Type of study: Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2015 Document type: Article Affiliation country: Estados Unidos